Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions... Show more
PGNY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 37 cases where PGNY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PGNY just turned positive on June 03, 2025. Looking at past instances where PGNY's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PGNY advanced for three days, in of 329 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where PGNY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on June 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PGNY as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
PGNY moved below its 50-day moving average on May 19, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PGNY crossed bearishly below the 50-day moving average on May 21, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PGNY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools